tiprankstipranks
Advertisement
Advertisement
Oryzon Genomics announces first patient dosed in Phase Ib iadademstat study
PremiumThe FlyOryzon Genomics announces first patient dosed in Phase Ib iadademstat study
2M ago
Oryzon Genomics receives Decision to Grant from Japanese Patent Office
Premium
The Fly
Oryzon Genomics receives Decision to Grant from Japanese Patent Office
2M ago
Oryzon Genomics receives Decision to Grant from Japanese Patent Office
Premium
The Fly
Oryzon Genomics receives Decision to Grant from Japanese Patent Office
4M ago
Oryzon Genomics Advances Phase III Trial for BPD Treatment
PremiumCompany AnnouncementsOryzon Genomics Advances Phase III Trial for BPD Treatment
10M ago
Oryzon Genomics Advances Phase III Trial for BPD Treatment
Premium
Company Announcements
Oryzon Genomics Advances Phase III Trial for BPD Treatment
10M ago
Oryzon Genomics Announces 2025 Shareholders Meeting
Premium
Company Announcements
Oryzon Genomics Announces 2025 Shareholders Meeting
11M ago
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
PremiumCompany AnnouncementsOryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
12M ago
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
Premium
Company Announcements
Oryzon Genomics Announces €25 Million Capital Increase for Clinical Expansion
12M ago
Oryzon Genomics SA Strengthens Governance and Financial Strategy
Premium
Company Announcements
Oryzon Genomics SA Strengthens Governance and Financial Strategy
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100